Researchers from the century institution in Australia have found that the “interruption of connection of the DPP9 protein in liver cells can prevent the early appearance of cancer tumors. Research Results published Biochimica Et Biophysica Acta (BBA) magazine.
In Australia, liver cancer identified more than three,000 people annually. This disease also constitutes 7.8% of all deaths from cancer.
To determine new ways to combat this disease, scientists focused on the roles of a dipperptidase 9 (DPP9) protein in the body of young mice. In mammals (including people), this protein plays a role in the regulation of inflammation, metabolism and cell survival.
During the experiment, scientists limited DPP9 activity in a group of rodents with liver cancer and then compared their health status with the control group. As a result, it was found that the disconnection of the gene caused a decrease in blood sugar and the amount of tumor foci in the liver, as well as the risk of obesity.
“Removal of DPP9 from liver cells triggers an internal healing reaction, increases the body’s resistance and reduces the risk of cancer,” the researchers said.
Scientists said that new data leads to the development of new, safer approaches to the treatment of liver cancer. According to them, in some cases the DPP9 protein management can help avoid the use of chemotherapy. This type of drug treatment is effective, but when used, the risk of severe adverse reaction is high.
EARLY IN Russia Created A drug for cancer without analogs in the world.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.